40 likes | 56 Views
Nuclear medicine consists of therapeutic techniques and diagnostic procedures that are carried with radioisotopes. Two widely known technologies that are used in nuclear medicines are Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). PET comprises radiotracers that emit tiny particles termed as positrons that finally decays out to produce gamma rays used for detection. However, SPECT uses X-rays to lower energy and detect. This radiopharmaceutical medicine is used to study the disease progression and track the tissue function of neurological disorders, oncology, and cardiovascular.<br><br>Browse full report atu00a0https://www.omrglobal.com/industry-reports/nuclear-medicine-market<br>
E N D
Orion Market Research Nuclear Medicine Market, by Technology (PET, SPECT), by Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy), by Application (Thyroid, Neurology, Oncology, Cardiology, Others) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025 ------------------------------------------------------------------------------------ Email: info@omrglobal.com Phone: +91 780-304-0404, +1 646-755-7667 The global nuclear medicine market is growing at a significant CAGR during the forecast period. The market growth is driven by the significant need to minimize and mitigate the risk of accidental radiation
exposure to the patient. Nuclear medicine is a medical technology that uses radioactive traces to examine organ functions, structure and treating diseases. It is a specialized area of radiology in which very small amounts of radioactive elements or radiopharmaceuticals are used due to which it has significant demand in the medical industry. Two most commonly used nuclear medicine imaging include Single Photon Emission Computed Tomography and Positron Emission Tomography. To know more information, please request a free report sample https://www.omrglobal.com/request- sample/nuclear-medicine-market Nuclear medicine is used to treat various diseases and abnormalities primarily at the early stage such are thyroid cancer, hyperthyroidism, lymphomas and bone pain from some types of cancer. This will create enormous opportunities for the nuclear medicine market across the globe. One of the major factors driving the growth is the unreliability of X-ray. X-ray passes through soft tissues such as muscles, intestines, and blood vessels and so on. It is very hard to make a visual image of these tissues. On the other hand, nuclear medicine is capable of capturing visual images as well as functions of these organs and tissues. The level of function of the organs or tissues is indicated by the extent up to which radiopharmaceutical is absorbed. Thus, to study organs and tissue, the demand for nuclear imaging is rising across the globe. Sometimes gathering information about the patient's organs or tissues affected by diseases is more expensive and can be pain-inducing or risky. However, nuclear medicine is painless, safe and it can gather information very easily and on top of that, it is cost-effective too. Due to which more and more healthcare institutions are considering the use of nuclear medicine. Additionally, PET (positron emission tomography) scans and SPECT (Single Photon Emission Computed Tomography) scans are precise and accurate than traditional scans. These scans can be used in integration with CT scan too by which the results are more precise and accurate than ever. Doctors are preferring nuclear medicine more which drives the growth of the nuclear medicine industry. Visit here to know more about Global Nuclear Medicine Market Size This medical technology is able to identify the diseases and abnormalities very early before any medical issue is visible with the help of other diagnostic tests. Due to which, the disease can be treated early in its course before it spreads or gets worse. Moreover, other than diagnostic purpose nuclear imaging has other valuable therapeutic applications too including blood imbalances, thyroid cancer, hyperthyroidism and other types of cancers too. Additionally, too much radiation can lead to increased risk of cancer however, radiations levels of nuclear medicine is really less and can be compared to CT scan or X-ray. As a result, these medicines are considered non-invasive and safe. Hence increase the market growth of the nuclear medicine market.
Browse the full report of "Nuclear Medicine Market, by Technology (PET, SPECT), by Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy), by Application (Thyroid, Neurology, Oncology, Cardiology, Others) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/nuclear-medicine-market Global Nuclear Medicine Market-Segmentation by Technology •Positron Emission Tomography (PET) •Single Photon Emission Computed Tomography (SPECT) By Therapeutics •Alpha Emitters •Beta Emitters •Brachytherapy By Application •Thyroid •Neurology •Oncology •Cardiology •Others (Gastrointestinal) Global Nuclear Medicine Market -Regional Analysis North America •US •Canada Europe •Germany •UK •France
•Spain •Italy •Rest of Europe Asia-Pacific •China •India •Japan •Rest of Asia-Pacific Rest of the World •Middle East & Africa •Latin America About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Nuclear Medicine Market